ICMS IRB
The ICMS maintains an HHS sanctioned Institutional Review Board. The mission of this IRB is to provide peer oversight in the evaluation of patient safety of proposed studies.
All ICMS members may apply to serve on the ICMS IRB. IRB members are entitled to present studies for review and to engage in the review of other studies.
Application for Review
Physicians may present studies for review by filling out the Application for Review. Applications for review are due no later than the 1st of the month for which the review will take place.
Determinations from the ICMS IRB will take anywhere from 48 hours to 14 days. Requesting physicians are required to present their study to the IRB.
Approval for any proposed study is based upon the ICMS Guidelines for the Practice of Cell Based Medicine. Physicians interested in presenting to the ICMS IRB must be able to provide:
· Evidence of safety via animal models or other studies presented in peer-review journals
· Physician qualification and training.
· Patient Informed Consent
· Inclusion and Exclusion Criteria
· Scientific and Medical Rationale for the Use of Cell Based Medicine
Cost
ICMS Members: $750 (standard study)
Non-ICMS Members: $2,000 (standard study)
Non-Standard Studies (as determined by the ICMS) will be priced accordingly
Scheduled Meetings
The ICMS IRB meets quarterly, via tele-conference, on the 2nd Tuesday of every month.
Current ICMS IRB Members
David Audley (ex-officio)
Membership
All ICMS members may apply to serve on the ICMS IRB. IRB members are entitled to present studies for review and to engage in the review of other studies.
For an application to serve on the ICMS IRB, click HERE
Oversight:
The ICMS IRB is governed by by Title 45 CFR (Code of Federal Regulations) Part 46. IRBs are themselves regulated by the Office for Human Research Protections (OHRP) within HHS.
ICMS IRB: Non Disclosure Agreement
For an application to serve on the ICMS IRB please·contact us.
Institutional Review Board





